Treatment of Cushing's disease in childhood and adolescence by stereotactic pituitary irradiation.
Eight children with Cushing's disease aged 6-18 years were treated with external radiation to the pituitary gland using 60Co gamma radiation given with stereotactic technique. The dose given varied between 50 and 70 Gy. The observation time was 2.6 to 6.75 years. Seven children had a clinical remission with normal urinary cortisol excretion. One child had insufficient effect of two irradiations and underwent bilateral adrenalectomy. In the patients in remission the growth velocity increased during the first year after treatment but growth retardation occurred again during the second year. Insufficient growth hormone secretion was demonstrated in all subjects. Two patients were given thyroxine substitution and three showed evidence for secondary hypogonadism. In conclusion, stereotactic pituitary irradiation was effective in normalizing the excessive glucocorticoid production in children with Cushing's disease. However, with the doses used, it was not possible to maintain a normal anterior pituitary function.
D000293:Adolescent; D000324:Adrenocorticotropic Hormone / Q000097:blood; D002648:Child; D003037:Cobalt Radioisotopes / Q000627:therapeutic use; D003480:Cushing Syndrome / Q000097:blood / Q000532:radiotherapy*; D005260:Female; D005500:Follow-Up Studies; D006128:Growth / Q000528:radiation effects; D006801:Humans; D007334:Insulin-Like Growth Factor I / Q000097:blood; D007335:Insulin-Like Growth Factor II; D008297:Male; D010910:Pituitary Irradiation / Q000379:methods*; D011879:Radiotherapy Dosage; D013002:Somatomedins / Q000097:blood; D013238:Stereotaxic Techniques
D003037:Cobalt Radioisotopes; D013002:Somatomedins; D007334:Insulin-Like Growth Factor I; D007335:Insulin-Like Growth Factor II; D000324:Adrenocorticotropic Hormone